Systemic Lupus Erythematosus Clinical Trials Database - Free Access to 443 Studies
Access comprehensive clinical trial information for Systemic Lupus Erythematosus through Pure Global AI's free database. This collection includes 443 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 79 trials are actively recruiting participants.
Research for Systemic Lupus Erythematosus is being conducted in United States of America, China, Egypt and 7+ other countries. Leading sponsors include GlaxoSmithKline and Assiut University. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Study of Abetimus Sodium in Lupus Patients With History of Renal Disease
A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Moderate to Severe Systemic Lupus Erythematosus
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE)
CD19/BCMA HLA-independent TCR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus
Belimumab in SLE Synovial Inflammation and Lymph Nodes
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE)
FT819 in Moderate to Severe Active Systemic Lupus Erythematosus
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus
Fatigue in Lupus Intervention Programmes (FLIP)
A Study of CNTY-101 in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE)
Pure Global AI provides free access to 443 clinical trials studying Systemic Lupus Erythematosus, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include GlaxoSmithKline, Assiut University, UCB Pharma, among others.